SEC Filings
Puma CEO Auerbach Files 13D Amendment Only Because A $16.00 Warrant Expired Worthless
The filing shows Alan Auerbach still holds about 16% of Puma Biotechnology, with no new demands attached to the amendment.
SEC Filings
The filing shows Alan Auerbach still holds about 16% of Puma Biotechnology, with no new demands attached to the amendment.
SEC Filings
The Schedule 13G lands a day after Skyworks closed its Qorvo combination, with sole voting power over all shares reported.
SEC Filings
Kevin Tang's firm and its affiliated funds list shared voting power over all 4,814,700 shares, and say they hold them without seeking control.
SEC Filings
The 8-K says no disagreements prompted the exit, and Davis also received 51,626 fully vested restricted stock units.
SEC Filings
The company plans to hand Hess Midstream its stake and DJ Basin assets, with closing targeted by year-end 2026.
SEC Filings
The rest of the debt facility hinges on optional draws, a Danon disease milestone and lender approval, the 8-K says.
SEC Filings
The notes mature in 2029, 2032 and 2036 and carry coupons from 1.6803% to 2.4150%, with the parent and its operating partnership as guarantors.
SEC Filings
The notes priced at 99.289% of face value, with proceeds tied to the company's Green Bond Framework and closing set for Friday.
SEC Filings
An 8-K says the general counsel and corporate affairs chief is leaving "to pursue other opportunities" and names no replacement.
SEC Filings
An 8-K says Andrew Castellaneta's exit involved no disagreement, and the board filled the post the same day with a 44-year-old insider.
SEC Filings
Marc Schroeder, President, International, stays through December 31, 2026, then advises until February 15, 2027, the company's 8-K says.
SEC Filings
A Schedule 13D/A shows the group's stake fell from about 53.2% to about 51.7%, with no trades in 60 days and no new plans.